ArticleCancer immunology, immunotherapy : CII2011

Low-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer.

Qiushan He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.